LPTX News and Press, Leap Therapeutics Inc. From 11/10/20

Leap Therapeutics to Present at Stifel 2020 Healthcare Conference PR Newswire CAMBRIDGE, Mass., Nov. 10, 2020 CAMBRIDGE, Mass. , Nov. 10, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted a...

Gainers: Sundial Growers (SNDL) +79%.Aptevo Therapeutics (APVO) +60%.AMC Entertainment (AMC) +60%.Ashford Hospitality Trust (AHT) +58%.Cinemark Holdings (CNK) +56%.National CineMedia (NCMI) +48%.Tuniu (TOUR) +41%.EPR Properties (EPR) +41%.Dave & Buster's Entertainment (PLAY) +40%.Bro...

Leap Therapeutics Presents DKN-01 Monotherapy Data at AACR Virtual Special Endometrial Cancer Conference - Single Agent Activity Observed for DKN-01 in Recurrent Endometrial Cancer - Clinical Responses and Longer Progression-Free Survival in Patients with Wnt Signaling Alter...

Leap Therapeutics Presents Updated Data for DKN-01 in Esophagogastric Cancer Patients at SITC 2020 35th Annual Meeting - High Levels of Tumoral DKK1 Expression Correlated with Improved Clinical Outcomes in Heterogenous Esophagogastric Cancer Patients Treated with DKN-01 as a Mon...

Are These Biotech Penny Stocks On Your Watch List Right Now? Whether you’re trading penny stocks or blue chips , the goal is the same: make money and repeat. However, with a potentially new President coming into office, there could be a few things to monitor right now. Fi...

Two new breakout stocks for Week 46 with better than 10% short-term upside potential. This past week three out of four stocks gained more than 10% closing with gains to Friday with AVNS +8.54%, IMVT +14.96%, YY +10.85% with top average portfolio gains of 11.14%. The streak of week...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Annual Meeting PR Newswire CAMBRIDGE, Mass., Oct. 15, 2020 CAMBRIDGE, Mass. , Oct. 15, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focus...

Leap Therapeutics initiates Phase 2a trial for DKN-01. MacroGenics reports progress on MGA012 development. BridgeBio Pharma starts Phase 2 encaleret trial. For further details see: Leap Therapeutics Initiates Trial, And Other News: The Good, Bad And Ugly Of Biopharma

Sunworks (SUNW) +355%.Polar Power (POLA) +88%.The E.W. Scripps Company (SSP) +68% on ION Media acquisition.SPI Energy (SPI) +51%.LogicBio Therapeutics (LOGC) +45%.Owens & Minor (OMI) +28% after raising full-year guidance.Electrameccanica Vehicles (SOLO) +16% ...